A man living with HIV proudly sitting with his house plants

HIV TREATMENTS HAVE CHANGED

FEWER TABLETS,[1] FEWER MEDICINES,[1] AND LONG-ACTING INJECTIONS[2] ARE NOW OPTIONS TO HELP PEOPLE LIVING WITH HIV THRIVE

Download the conversation guide

As a trusted healthcare professional, you play a crucial role in helping your patients navigate their treatment options and achieve the best possible outcomes.

The Positive Perspectives 2 study identified key insights that highlight the need for improved treatment optimisation:[3,4]

NA
0%
(1098/2389) of people living with HIV reported being not fully satisfied with both their overall HIV medication and management.[4]

NA
0%
(1,556/2,389) of people living with HIV would like to be more involved in decisions about their HIV treatment.[3]

NA
0%
(639/1,056) of people living with HIV who were fully satisfied with their medication still reported some level of dissatisfaction with their overall HIV management.[3]

With the right and regular conversation, you can empower people living with HIV to thrive.

Why regular conversations matters:

  • Patient Empowerment

    Engaging your patients in conversations about their treatment options can empower them to take an active role in managing their health.[4]

  • Optimised Treatment

    With the evolving landscape of HIV treatments, a wider range of options is now available. Discussing these options can help ensure that each patient is on the treatment regimen that best fits their health and lifestyle needs.[4]

  • Improved Adherence

    Patients who feel involved in their treatment decisions are more likely to adhere to their regimen, leading to better health outcomes.[6]

  • Enhanced Health-Related Outcomes 

    Good quality healthcare professional-patient engagement may be associated with better health-related outcomes.[4]

  • Building rapport through open and active dialogue 

    Open discussions with HCPs can help patients feel empowered, educated and informed about their therapy choices. These engagement are associated with better health outcomes, and improving the quality of communication may better support the goal set out in Australia's National Strategy on HIV (2024-2030) to achieve 95% of people living with HIV reporting a good quality of life by 2030.[3,7]

POZQOL QUALITY OF LIFE MEASUREMENT

In addition to regular conversations about treatment optimisation, remember to regularly discuss quality of life with your patients and complete the PozQoL Digital Tool—a validated quality of life measurement tool designed for people living with HIV. Watch the video for more information about the PozQoL tool.

Measure PozQoL with your patient

Learn more

A man living with HIV relaxing at home with his dog

To support these important discussions

Check out this Conversation Guide, designed to facilitate meaningful discussion with your patients about their treatment goals, concerns and options.

This guide has been developed in paid consultation with 2 nurses and 1 pharmacist.

Download the conversation guide

PBS Information: These products are listed on the PBS as section 100 items. Refer to PBS Schedule for full authority information.

Please review DOVATO and CABENUVA Product Information before prescribing. Full Product Information is available from ViiV Healthcare Australia at www.viivhealthcare.com.au or on 1800 499 226.

References:

  1. DOVATO Australian Product Information.
  2. CABENUVA Australian Product Information.
  3. Positive perspectives study wave 2 results report: A view into the lives of people living with HIV. Available: https://viivhealthcare.com/content/dam/cf-viiv/viiv-healthcare/en_GB/files/29-06-30_PP2_global_results_report.pdf
  4. de Los Rios P, et al. Popul. Med. 2020;2(July):23.
  5. Okoli C, et al. AIDS Behav. 2021 May;25(5):1384-1395.
  6. Chen WT, et al. J AIDS Clin Res. 2013 Nov 1;4(11):256.
  7. Ninth National HIV Strategy 2024-2030. Australian Government Department of Health and Aged Care. Available at: https://www.health.gov.au/resources/publications/ninth-national-hiv-strategy-2024-2030 (Date accessed February 2025)

PM-AU-HVX-WCNT-250001 Date of preparation: March 2025.